TMDX
TransMedics Group, Inc.
$67.84
-6.94%
2026-05-08
About TransMedics Group, Inc.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Key Fundamentals
P/E Ratio
16.07
Forward P/E
19.66
EPS (TTM)
$4.37
ROE
45.2%
Revenue Growth (YoY)
21.2%
Profit Margin
27.0%
Debt/Equity
174.78
Price/Book
5.09
Beta
2.06
Market Cap
$2.43B
Avg Volume (10D)
2.0M
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$151.00
60D Low
$67.69
Avg Volume
1.1M
Latest Close
$67.84
Get breakout alerts for TMDX
Sign up for Breakout Scanner to receive daily notifications when TMDX triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
TransMedics Group, Inc. (TMDX) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors TMDX daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. TMDX operates in the Healthcare sector within the Medical Devices industry. Data is provided for informational purposes only and does not constitute financial advice.